BPRRX Mutual Fund

NAV$14.45

Fund Essentials - as of Dec 31, 2025

Net Assets
$6M
Expense Ratio
2.09%
Dividend Yield (Current)
10.60%
Holdings
10
Inception Date
Nov 29, 2010
Fund Family
Boston Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.53%
1 Year+13.96%
3 Year+13.46%
5 Year+13.11%
10 Year+8.31%

Asset Allocation

Stocks: 100.00%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
FTDRFrontdoor Inc1.20%
JPM:USJp Morgan Chase & Co1.20%
WFC V3.9 PERP BBWells Fargo And Coperpetual Bonds1.20%
ABBVAbbvie Inc Health Care1.10%
GOOGAlphabet Inc series C1.00%
Top 10 Concentration: 8.30%Report Date: Dec 31, 2025
Download all 10 holdings for BPRRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.60%
Frequency
Annually
Latest Distribution
$2.00
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how BPRRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

BPRRX Mutual Fund Overview

BPRRX Mutual Fund (Boston Partners Long/Short Research Fund Investor Class) is managed by Boston Partners with $5.8M in net assets. BPRRX expense ratio is 2.09%, holding 10 positions across sectors including Financials, Unknown, Consumer Discretionary. Inception date: 2010-11-29.

BPRRX performance shows a YTD return of 5.53%. The 1-year return is 13.96% and the 5-year return is 13.11%. BPRRX dividend yield stands at 10.60%, paid annually.

BPRRX top holdings include Frontdoor Inc (1.2%), Jp Morgan Chase & Co (1.2%), Wells Fargo And Coperpetual Bonds (1.2%), Abbvie Inc Health Care (1.1%), Alphabet Inc series C (1.0%). View all BPRRX holdings, sector breakdown, or dividend history.

BPRRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. BPRRX alternatives are available via the screener, along with tax-loss harvesting opportunities.